The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019

Amendment of regulation 159 (provisional determination)U.K.

This adran has no associated Memorandwm Esboniadol

133.  In regulation 159(1)—

(a)insert “ UK ” before “marketing authorisation”; and

[F1(b)for “Article 126a authorisation” insert “, only in relation to a product for sale or supply in Northern Ireland, an Article 126a authorisation or an EU marketing authorisation,”.]

Textual Amendments

F1Reg. 133(b) substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 100

Commencement Information

I1Reg. 133 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1